Exodus Point Capital Management, LP Myriad Genetics Inc Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 61,684 shares of MYGN stock, worth $471,265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61,684
Previous 148,693
58.52%
Holding current value
$471,265
Previous $1.32 Million
75.13%
% of portfolio
0.0%
Previous 0.01%
Shares
11 transactions
Others Institutions Holding MYGN
# of Institutions
234Shares Held
95.2MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$116 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$70.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$37.6 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$36.7 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$35 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $616M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...